• Oct 09, 2017 | Webcast

    Is Now the Time for Surrogate Endpoints in Osteoporosis?

    Gayle Lester, Ph.D., Mary Bouxsein, Ph.D., Dennis Black, Ph.D., Sundeep Khosla, M.D., Theresa Kehoe, MD., CDER, FDA
    Skeletal Physiology, Molecular Cellular and Genetic Determinants of Bone Structure and Formation, Integrative Physiology of the Skeleton

    Co-Chairs:

    Gayle Lester, Ph.D., National Institutes of Arthritis, Musculoskeletal & Skin Disease, USA  and Mary Bouxsein, Ph.D., Beth Israel Deaconess Medical Center, Harvard Medical School, USA

     

    Introduction

    Gayle Lester, Ph.D., National Institutes of Arthritis, Musculoskeletal and Skin Disease, USA

     

    The FNIH Bone Quality Study

    Dennis Black, Ph.D., UC San Francisco, USA

     

    Clinical Perspective: What Do We Need?

    Sundeep Khosla, M.D., Mayo Clinic College of Medicine, USA

     

    Panel Discussion

    Dennis Black, Ph.D., UC San Francisco, USA

    Theresa Kehoe, M.D., CDER, FDA, USA

    Sundeep Khosla, M.D., Mayo Clinic College of Medicine, USA

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details